X63-11038-83775
2 vaccinations
3 coded responses
21 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 452 / OH
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- A3H-15485-19415
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-30
Registered in v-safe
-
2022-06-30
Dose 1 — Pfizer-BioNTech
- 2022-06-30
- 2022-07-01
-
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-07-03
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/crying, Loss of appetite, DiarrheaUnder 3 check-in
-
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Poor · Irritability/crying, Loss of appetite, Diarrhea · Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-07-06
- 2022-07-09
-
2022-07-15
Survey response — day 14, dose 1, under 3MedDRA: Cough, Irritability, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cold symptoms: cough, congestion, runny nose, irritabilityMedDRA releases: 2024-11 · check-in free text available
-
2022-07-21
Dose 2 — Pfizer-BioNTech
- 2022-07-21
-
2022-07-22
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
-
2022-07-23
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-24
- 2022-07-27
- 2022-07-28
- 2022-08-04
-
2022-08-11
Survey response — day 21, dose 2, under 3MedDRA: Bronchial hyperreactivity, Rhinovirus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with rhinovirus and reactive airway requiring albuteral 3x dayMedDRA releases: 2024-11 · check-in free text available
-
2022-08-11
Report sent to call center — day 21, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-12
- 2022-08-18
- 2022-08-25
- 2022-09-01
-
2022-10-20
Survey response — 3 months, dose 2, under 3MedDRA: Cough, Decreased appetite, Diarrhoea, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diarrhea, congestion, cough, poor appetiteMedDRA releases: 2024-11 · check-in free text available
- 2023-01-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-30 | Pfizer-BioNTech | No |
| 2 | 2022-07-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Cold symptoms: cough, congestion, runny nose, irritability
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Diagnosed with rhinovirus and reactive airway requiring albuteral 3x day
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Diarrhea, congestion, cough, poor appetite
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchial hyperreactivity | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Rhinovirus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release